Fintech PR
HNSS: World’s Unique Project by MEIL
Reading Time: 3 minutes
There are many lift irrigation projects in the world, but, the Handri Neeva Sujala Sravanthi (HNSS) project has unique features among all. This lift irrigation project is having the highest number of pump houses and motors in the world. 43 pump houses built in the first and second phases of the project. By establishing a total of 269 units (motor and pump is one unit), MEIL has created a world-class project.
HNSS is Asia’s biggest and longest lift irrigation project. Explaining the reasons to be the biggest, Mr. Rammohan Reddy, General Manager MEIL, said, “Though Kaleshwaram, Devadula, Kalwakurthy, Palamuru-Rangareddy projects are bigger projects, as they are still under execution level, HNSS is recognised as Asia’s biggest lift irrigation project. The California state in the USA is having the world’s biggest project which was built 80 years ago. This project lifts water to the highest levelof terrains for drinking and irrigation purposes. Once the Kaleshwaram lift irrigation project completes, all these records will be erased out. As per the number of motors, pumps, pump houses and length, HNSS is Unique amongst all. MEIL’s electro-mechanical works had brought this uniqueness to the project. ”
Handri-Neeva project was proposed 30 years ago with the ambition to supply drinking and irrigation water to the four Rayalaseema districts. While the river Handri flows in Kurnool district and Neeva flows in Chittoor district, these two rivers are interlinked by digging hills and high terrains by setting up a pump house at Malyala in Kurnool district. When this project was taken up in 2006, there were many questions and critics about the availability of water and financial resources. Many pessimists raised questions regarding establishing and maintenance of pumps and motors.
“MEIL successfully executed the first phase of HNSS along with maintaining and pumping the water for the last eight years without any issues or hindrances . MEIL proved that whether it is Colorado or Rayalaseema, the lift irrigation projects can be implemented successfully. In the first phase of the project, 12 pump houses with 129 units (motors and pumps) are successfully running for the last 8 years,” said Rammohan Reddy, General Manager, MEIL.
As part of the second phase, water pumping is going on in 565-kilometre length main canal through Madakashira and Punganoor branch canal. This main canal spread across Ananthapur, Kadapa, Chittoor districts. The water pumping into the main canal began in this season. 140 units in 31 pumping stations are ready to operate. As per the limitations of first year of operation, it is currently operating only 43 units. With these units, as of now, 160 tmc of water is lifted from Malayala in Kurnool district to the endpoint in Chittoor district. This water is lifted with the help of 43 pump houses. Explaining the uniqueness of the project, Rammohan Reddy said, “As two phases of the project are working now, it has become one of the world’s biggest and longest unique projects. Even China or the U.S., which includes world-renowned California state water project, do not have these many pump houses.Colorado state water project has only 6 to 11 pumping stations. The motors’ capacity in the Colorado project works with horsepower of electricity whereas in Handri-Neeva, pump houses works with megawatts of power. With the capacity of the unit taken into consideration, HNSS pump houses are established with the highest capacity.”
Even in India, particularly in Andhra Pradesh and Telangana, there are many lift irrigation projects built. In completed irrigations projects, no lift irrigation project has these many pumping stations. Under-construction projects like Devadula project has 20 pump houses, Kalwakurthy has 15, Rajivbheema has 20, Seetharama has 19 and Gandikota project has 14 pump houses. Once the Kaleshwaram project is completed, the 82 pump houses will come into the utilisation.
MEIL has the honour to create this world’s uniquely biggest and longest project. The construction first phase completed in 2012 with 12 pump houses which were inaugurated by the Government. These 12 pump houses pumped the water to an average height of 200 meters. Under the second phase, water was pumped to Ananthapur, Kadapa, Chittoor districts from Jeedipally reservoir for drinking and irrigation purposes. This second phase was inaugurated this year by the State Government. Under the HNSS project, 40 tmc of water can be lifted to supply water to 6.25 lakh acres of agricultural lands and drinking water to 35 lakhs people in 437 villages of 81 mandals. The project was taken up prestigiously in 2006 by then Chief Minister of Andhra Pradesh.
Adding to the above innovative features,Rammohan Reddy elaborated, “Under the HNSS second phase, MEIL completed the construction works to supply irrigation water from Jeedipally reservoir to Madakashira branch canal to supply water to 4,04,500 acres. 19 pump houses were built to supply water to 74,400 acres in Penugonda, Hindupur, Madakashira constituencies through this canal.”
Water will be pumped to 18 pump houses across the 155.2-kilometre branch canal from Jeedipally pump house. On the Madakashira branch canal, MEIL established 81 pumps in L1 to L17 and L4A pump houses. MEIL also built 132/6.6KV power substation at Jeedipally pump house. 33/6.6 KV sub-stations were built at the remaining pump house by MEIL.
SOURCE Megha Engineering and Infrastructure Limited (MEIL)
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
“The Hainan FTP and Me”: Looking at Hainan’s Transformations
-
Latest News5 days ago
Millions of people unite around doing good on the 18th International Good Deeds Day held yesterday worldwide
-
Latest News4 days ago
Banxso Acquires Australian ASIC License, Enhancing Its Global Trading Operations
-
Latest News5 days ago
135th Canton Fair Launches a Showcase of Innovative Products of New Collection to Lead Global Market Trends
-
Latest News3 days ago
BMO Announces Election of Board of Directors
-
Latest News5 days ago
BII and FMO back BECIS with joint US$50 million financing facility supporting commercial and industrial renewables sector in South-East Asia
-
Latest News4 days ago
Fiat infrastructure Leader Banxa join forces with Venom foundation in offering Venom-supported tokens access to its global Fiat rails
-
Latest News5 days ago
Silent Eight secures AIA as its latest client